Laura Niccoli Selected Research

Laura Niccoli Research Topics

Disease

11	Rheumatoid Arthritis 08/2023 - 01/2009
11	Psoriatic Arthritis 11/2019 - 08/2003
8	Ankylosing Spondylitis 01/2020 - 10/2006
6	Tuberculosis (Tuberculoses) 07/2020 - 05/2014
5	Infections 08/2023 - 04/2016
4	Uveitis 12/2017 - 01/2012
3	COVID-19 12/2020 - 01/2020
3	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2017 - 01/2012
2	Neoplasms (Cancer) 08/2023 - 06/2009
2	Rheumatic Diseases (Rheumatism) 03/2020 - 01/2019
2	Anterior Uveitis 04/2016 - 11/2015
2	Latent Tuberculosis 04/2016 - 06/2015
2	Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis) 02/2005 - 04/2003
1	Venous Thromboembolism 08/2023
1	Herpes Zoster 08/2023
1	Hypertension (High Blood Pressure) 08/2023
1	Obesity 05/2022
1	Venous Thrombosis (Deep-Vein Thrombosis) 05/2022
1	Thromboembolism 05/2022
1	Cytokine Release Syndrome 01/2021
1	Pneumonia (Pneumonitis) 10/2020
1	Giant Cell Arteritis (Horton Disease) 10/2019
1	Periodontal Diseases (Periodontal Disease) 01/2018
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 04/2016
1	Asbestosis 06/2015
1	Fibrosis (Cirrhosis) 06/2015
1	Autoimmune Diseases (Autoimmune Disease) 06/2015
1	Tenosynovitis 01/2013
1	Arthritis (Polyarthritis) 01/2013
1	Iridocyclitis 01/2013
1	Anemia 02/2012
1	Inflammation (Inflammations) 02/2012
1	Posterior Uveitis 01/2012
1	Disease Progression 10/2010
1	Necrosis 01/2008
1	Vasculitis (Vasculitides) 04/2004
1	Hypersensitivity (Allergy) 08/2003
1	Acquired Hyperostosis Syndrome (SAPHO Syndrome) 05/2003
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2003

Drug/Important Bio-Agent (IBA)

9	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019 - 05/2003
7	Infliximab (Remicade)FDA Link 12/2017 - 04/2003
4	Antirheumatic Agents (DMARD)IBA 08/2023 - 08/2003
4	baricitinibIBA 12/2020 - 01/2020
4	Adalimumab (Humira)FDA Link 01/2019 - 01/2012
3	Biosimilar PharmaceuticalsIBA 03/2020 - 12/2017
3	tocilizumab (atlizumab)FDA Link 10/2019 - 05/2014
3	CytokinesIBA 01/2017 - 04/2004
3	Etanercept (Enbrel)FDA Link 05/2014 - 10/2006
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2008 - 04/2003
2	GLPG0634IBA 08/2023 - 07/2020
2	Ustekinumab (CNTO 1275)FDA Link 10/2017 - 04/2016
2	Monoclonal AntibodiesIBA 04/2016 - 08/2003
2	Abatacept (Orencia)FDA Link 04/2016 - 05/2014
2	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2013 - 02/2005
2	Methotrexate (Mexate)FDA LinkGeneric 10/2010 - 01/2008
1	Janus Kinase InhibitorsIBA 08/2023
1	omega-Chloroacetophenone (Mace)IBA 08/2023
1	Rheumatoid FactorIBA 08/2023
1	Anti-Citrullinated Protein AntibodiesIBA 08/2023
1	COVID-19 VaccinesIBA 12/2022
1	mRNA VaccinesIBA 12/2022
1	Janus Kinase 1IBA 01/2021
1	Antiviral Agents (Antivirals)IBA 12/2020
1	remdesivirIBA 12/2020
1	Oxygen (Dioxygen)IBA 12/2020
1	Dexamethasone (Maxidex)FDA LinkGeneric 12/2020
1	upadacitinibIBA 07/2020
1	tofacitinibIBA 07/2020
1	Janus KinasesIBA 07/2020
1	ixekizumabIBA 01/2020
1	secukinumabIBA 10/2017
1	Biomarkers (Surrogate Marker)IBA 04/2016
1	HLA-B27 Antigen (HLA B27 Antigen)IBA 11/2015
1	canakinumab FDA Link 06/2015
1	AutoantibodiesIBA 06/2015
1	Interleukin-1beta (Interleukin 1 beta)IBA 06/2015
1	Cytidine Triphosphate (CTP)IBA 05/2014
1	Rituximab (Mabthera)FDA Link 05/2014
1	golimumab FDA Link 05/2014
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 05/2014
1	Certolizumab Pegol FDA Link 05/2014
1	Sulfasalazine (Azulfidine)FDA LinkGeneric 10/2010
1	AnticoagulantsIBA 01/2008
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2008
1	Interferon-gamma (Interferon, gamma)IBA 04/2004
1	SteroidsIBA 04/2003
1	AntibodiesIBA 01/2003

Therapy/Procedure

13	Therapeutics 08/2023 - 04/2003
5	Biological Therapy 05/2022 - 06/2015
2	Drug Tapering 10/2019 - 01/2012
1	Intravenous Infusions 12/2017